Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

INBXINBX
9 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in INHIBRX BIOSCIENCES INC

Yes. Schonfeld Strategic Advisors holds 697,586 shares of INBX (Inhibrx Biosciences), worth $66.1M, as of its Q2 2026 13F filing. It increased the position by 442,759 shares (+173.8%) from Q1 2026. Schonfeld Strategic Advisors has held INBX in every 13F on record since Q2 2024, 9 quarterly filings. INBX is 0.2% of Schonfeld Strategic Advisors' reported 13F portfolio.

Current Value

$66.1M

Current Shares

697,586

Total Value Change

+$65M

Total Shares Change

+621,606

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
697,586
+173.8%
$66.1M0.2%$94.75
57
2026-Q1
Increased
254,827
+18.7%
$17.1M0.1%$74.33
40
2025-Q4
Increased
214,725
+120.5%
$17M0.1%$77.98
46
2025-Q3
Decreased
97,382
-37.1%
$3.3M0.0%$32.31
0
2025-Q2
Increased
154,790
+7.4%
$2.2M0.0%$14.43
28
2025-Q1
Unchanged
144,178
0.0%
$2M0.0%$14.12
0
2024-Q4
Unchanged
144,178
0.0%
$2.2M0.0%$15.14
0
2024-Q3
Increased
144,178
+89.8%
$2.3M0.0%$15.52
41
2024-Q2
New
75,980
-
$1.1M0.0%$14.17
35

Other major holders of INBX: MORGAN STANLEY, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used